New Bill: No War in North Korea Without Congressional Authorization
WASHINGTON – U.S. Senator Chris Murphy (D-Conn.) on Tuesday led U.S. Senators Tammy Duckworth (D-Ill.), Brian Schatz (D-Hawaii), Cory Booker (D-N.J.), Bernie Sanders (I-Vt.), Jeff Merkley (D-Ore.), Elizabeth Warren (D-Mass.), and Tom Udall (D-N.M.) in introducing a bill prohibiting President Trump from starting a preemptive war against North Korea, absent an imminent threat or without express authorization from Congress. The bill, introduced amidst the escalation
Sanders Statement on Special Counsel Indictments
NEW YORK, Oct. 30 – U.S. Sen. Bernie Sanders (I-Vt.) issued the following statement Monday after President Donald Trump’s former campaign chairman, Paul Manafort, and a former Manafort business associate, Rick Gates, were indicted: “Russia’s interference in our recent election and their attack on American democracy is an issue of enormous consequence. Special Counsel Mueller, appointed with bipartisan support, is
Top Dems Introduce Bill to Allow HHS to Negotiate Lower Drug Prices for Medicare
WASHINGTON, Oct. 25 —Today, Rep. Elijah E. Cummings (D-Md.), the Ranking Member of the House Committee on Oversight and Government Reform, Sen. Bernie Sanders (I-Vt.), Sen. Patrick Leahy (D-Vt.) Rep. Lloyd Doggett (D-Tx.), and Rep. Peter Welch (D-Vt.) introduced The Medicare Drug Price Negotiation Act of 2017 to direct the Secretary of the Department of Health and Human Services (HHS) to negotiate lower
Minimum Wage Too Low to Keep Working Families Out of Poverty, New Report Finds
WASHINGTON, Oct. 23 – The federal minimum wage is leaving millions of families in poverty, according to a new study prepared by the Government Accountability Office for Sen. Bernie Sanders (I-Vt.). While 20 percent of working families earning the $7.25 minimum wage or below live in poverty, 13 percent of families with a worker earning up to $12 per hour live in
Sanders Statement on New $373,000 Cancer Therapy
WASHINGTON, Oct. 19 – Sen. Bernie Sanders (I-Vt.) issued the following statement Thursday after the pharmaceutical company Gilead said the list price for the cancer drug Yescarta would be $373,000: “Gilead, one of the greediest pharmaceutical corporations in the world, is once again gouging Americans dealing with a life-threatening illness. This time, Gilead plans to charge an outrageous $373,000 per
